• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 7
  3. Author

Online ISSN: 2515-8260

Volume9, Issue7

An Overview of Different Analytical Methods Reported for the estimation of Flupirtine, Fluindione, Mizolastine, and Dapoxetine Including Impurity Profiling

    Birendra Shrivastava, Tattari Praveenkumar, Alavala Manikanta Kumar

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 7, Pages 4782-4809

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Quantitative research necessitates an awareness of the actual or average amount of substances present in the sample and makes use of two methods of analysis based on the composition of the material present in the sample. These methods are known as traditional chemical analysis and instrumental analysis, respectively. Quantitative research needs one to be aware of the real or average quantity of chemicals that are present in the sample. In this article, we take a look at the many analytical techniques that have been published for the estimation of flupirtine, fluindione, mizolastine, and dapoxetine in bulk as well as in their particular dosage forms. This study also covers the methods for impurity profiling. It was found that very little work has been done on the chosen medications, and very few techniques have been described for the estimate of pharmaceuticals in bulk and their formulations. This is a problem since there is a great need for this information. There have been no methodologies that have been published on the chosen pharmaceuticals for the purpose of estimating contaminants linked to their synthetic pathway or packaging-related issues. As a result, we have chosen the medications listed above in order to create methodologies for estimating the impurities associated with these drugs
Keywords:
    RP-HPLC Impurity profiling Method development Validation Quantitative analysis
  • PDF (415 K)
  • XML
(2022). An Overview of Different Analytical Methods Reported for the estimation of Flupirtine, Fluindione, Mizolastine, and Dapoxetine Including Impurity Profiling. European Journal of Molecular & Clinical Medicine, 9(7), 4782-4809.
Birendra Shrivastava, Tattari Praveenkumar, Alavala Manikanta Kumar. "An Overview of Different Analytical Methods Reported for the estimation of Flupirtine, Fluindione, Mizolastine, and Dapoxetine Including Impurity Profiling". European Journal of Molecular & Clinical Medicine, 9, 7, 2022, 4782-4809.
(2022). 'An Overview of Different Analytical Methods Reported for the estimation of Flupirtine, Fluindione, Mizolastine, and Dapoxetine Including Impurity Profiling', European Journal of Molecular & Clinical Medicine, 9(7), pp. 4782-4809.
An Overview of Different Analytical Methods Reported for the estimation of Flupirtine, Fluindione, Mizolastine, and Dapoxetine Including Impurity Profiling. European Journal of Molecular & Clinical Medicine, 2022; 9(7): 4782-4809.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 24
  • PDF Download: 37
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus